Skip to main content

Table 2 Clinical findings in Finnish patients with genetically confirmed ataxic disorders

From: Molecular epidemiology of hereditary ataxia in Finland

ID

Sex

AOO

AAE

Gene

CI

DM

E

HI

VI

PNP

Tonus

EyeM

Dysph

Dysar

KPS [18]

1

F

NA

NA

ATXN8/OS

-

-

-

-

-

-

NA

NA

NA

NA

NA

2

F

50

76

ATXN8/OS

-

-

-

 + 

-

-

N

N

 + 

-

80

3

F

57

72

ATXN8/OS

-

-

-

-

-

-

N

N

-

 + 

80

4

F

36

64

ATXN8/OS

-

-

-

-

-

-

N

N

 + 

 + 

70

5

F

35

36

ATXN8/OS

-

-

-

-

-

-

N

I

-

 + 

80

6

F

33

36

ATXN8/OS

-

-

-

-

-

-

N

N

 + 

 + 

80

7

M

40

64

ATXN8/OS

 + 

 + 

-

-

 + 

 + 

NA

NA

 + 

 + 

80

8

F

32

55

POLG

-

-

 + 

-

-

 + 

N

I

-

 + 

20

9

M

45

59

POLG

 + 

-

-

 + 

-

 + 

N

N

-

-

70

10

M

24

45

POLG

-

-

 + 

-

 + 

 + 

N

I

 + 

 + 

60

11

M

50

58

POLG

-

-

-

-

-

-

N

NA

-

 + 

80

12

F

30

43

POLG

-

-

-

-

-

 + 

N

I

-

-

80

13

F

40

42

POLG

 + 

 + 

-

-

 + 

 + 

N

I

 + 

 + 

80

14

F

40

72

RFC1

 + 

-

 + 

-

-

 + 

N

I

 + 

 + 

40

15

M

45

57

RFC1

-

-

-

-

-

 + 

N

I

-

 + 

60

16

F

52

64

RFC1

-

-

-

-

 + 

 + 

N

I

-

 + 

70

17

F

64

74

RFC1

-

 + 

-

-

-

 + 

N

I

 + 

 + 

50

18

M

48

71

RFC1

-

-

-

-

-

 + 

N

I

-

-

90

19

F

20

58

SACS

-

-

-

-

-

 + 

S, R

I

-

 + 

50

20

M

10

65

SACS

-

-

-

-

-

 + 

S

I

-

 + 

40

21

M

7

63

SACS

-

-

-

-

-

 + 

S

I

-

 + 

40

22

M

1

NA

CACNA1A

-

-

-

-

 + 

-

N

I

-

 + 

NA

23

M

10

44

CACNA1A

-

-

-

-

-

-

N

N

-

-

90

24

F

11

20

CACNA1A

-

-

-

-

-

-

N

N

-

-

90

25

F

5

37

FXN

-

 + 

-

-

-

 + 

S

I

-

 + 

50

26

F

22

29

FXN

-

-

-

-

-

 + 

S

I

-

-

80

27

M

20

64

MT-ATP6/8

-

 + 

-

 + 

-

 + 

N

N

 + 

 + 

60

28

F

20

59

MT-ATP6/8

-

 + 

-

-

-

-

N

N

-

 + 

60

29

F

32

38

SAMD9L

 + 

-

-

-

-

-

N

I

 + 

-

80

30

M

70

85

ATM

 + 

-

-

-

-

-

N

I

 + 

 + 

50

31

M

57

63

FMRI

 + 

-

-

-

-

-

N

N

 + 

 + 

80

32

F

2

28

RARS2

 + 

-

 + 

-

-

-

N

I

 + 

-

70

33

M

4

26

mtDNA del

 + 

 + 

-

 + 

 + 

-

N

I

-

-

40

  1. AAE age at examination, AOO age of onset, CI cognitive impairment, del deletion, DM diabetes mellitus, Dysar dysarthria, dysph dysphagia, E epilepsy, EyeM eye movements, HI hearing impairment, I impaired eye movements include double vision, impaired saccades, impaired smooth pursuit or nystagmus, KPS Karnofsky performance score, N normal, NA not analyzed, PNP polyneuropathy, R rigidity, S spasticity, VI visual impairment